LGHT vs. XPH ETF Comparison
Comparison of Langar Global HealthTech ETF (LGHT) to SPDR S&P Pharmaceuticals ETF (XPH)
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.
Grade (RS Rating)
Last Trade
$10.35
Average Daily Volume
915
31
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$46.34
Average Daily Volume
60,002
44
Performance
Period | LGHT | XPH |
---|---|---|
30 Days | -1.96% | -0.77% |
60 Days | -2.17% | 3.73% |
90 Days | -1.81% | 5.39% |
12 Months | 28.11% |
0 Overlapping Holdings
Symbol | Grade | Weight in LGHT | Weight in XPH | Overlap |
---|
LGHT Overweight 31 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
ISRG | A | 15.39% | |
GEHC | D | 8.56% | |
RMD | C | 6.71% | |
IQV | F | 6.34% | |
DXCM | C | 5.51% | |
PODD | C | 5.26% | |
VEEV | C | 5.15% | |
PHG | C | 4.87% | |
ZBH | C | 3.57% | |
BNTX | C | 3.53% | |
ALGN | D | 2.85% | |
MASI | B | 2.46% | |
DOCS | C | 2.06% | |
MRNA | F | 1.72% | |
PRCT | B | 1.27% | |
ALKS | C | 0.66% | |
TNDM | D | 0.54% | |
IRTC | C | 0.44% | |
PRVA | C | 0.44% | |
OMCL | C | 0.42% | |
LFST | B | 0.31% | |
TDOC | C | 0.28% | |
PGNY | F | 0.25% | |
EVH | F | 0.22% | |
SDGR | C | 0.21% | |
GDRX | F | 0.2% | |
ALHC | C | 0.2% | |
PHR | F | 0.17% | |
ACCD | D | 0.07% | |
MODV | C | 0.03% | |
TBRG | B | 0.03% |
LGHT Underweight 44 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
CORT | B | -4.96% | |
LBPH | A | -4.12% | |
BMY | B | -4.11% | |
ITCI | C | -4.01% | |
JAZZ | B | -3.94% | |
VTRS | A | -3.73% | |
AXSM | B | -3.59% | |
EWTX | C | -3.42% | |
CTLT | C | -3.41% | |
ELAN | D | -3.35% | |
PRGO | C | -3.35% | |
RPRX | D | -3.18% | |
JNJ | C | -3.17% | |
ZTS | D | -3.15% | |
PFE | F | -3.07% | |
LLY | F | -2.94% | |
MRK | D | -2.93% | |
TARS | C | -2.81% | |
OGN | F | -2.58% | |
SAVA | C | -2.57% | |
ARVN | F | -2.53% | |
PBH | A | -2.5% | |
SUPN | C | -2.15% | |
AMPH | F | -2.02% | |
PCRX | C | -1.91% | |
LGND | C | -1.77% | |
ANIP | F | -1.54% | |
COLL | F | -1.48% | |
OCUL | D | -1.44% | |
AMRX | C | -1.33% | |
MNMD | C | -1.23% | |
HRMY | D | -1.22% | |
WVE | C | -1.17% | |
HROW | D | -1.17% | |
INVA | D | -0.98% | |
EYPT | D | -0.94% | |
LQDA | F | -0.89% | |
PLRX | D | -0.87% | |
FULC | F | -0.85% | |
ELVN | D | -0.64% | |
NUVB | C | -0.6% | |
EOLS | D | -0.52% | |
PHAT | F | -0.48% | |
XERS | C | -0.46% |
LGHT: Top Represented Industries & Keywords
XPH: Top Represented Industries & Keywords